Clinical Trial Update: Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety and efficacy of adding saxagliptin to metformin XR versus metformin XR alone in adults with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Onglyza (Saxagliptin)
• metformin XR (metformin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2010-03-10